Advertisement

Mobile Banner
Mobile Banner
Mobile Banner
Loading...

Personalis, Inc.

PSNLNASDAQ
Healthcare
Medical - Diagnostics & Research
$8.29
$0.010(0.12%)
U.S. Market opens in 15h 52m

Personalis, Inc. (PSNL) Stock Overview

Explore Personalis, Inc.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap736.2M
P/E Ratio-9.67
EPS (TTM)$-0.83
ROE-0.38%
Fundamental Analysis

AI Price Forecasts

1 Month$6.58
3 Months$7.87
1 Year Target$11.52

PSNL Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Personalis, Inc. (PSNL) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 44.91, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $11.52.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -9.67 and a market capitalization of 736.2M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
0.12%
5-Day Change
-2.70%
1-Month Change
-18.49%
3-Month Change
-14.80%
6-Month Change
71.64%
Year-to-Date (YTD) Change
5.61%
1-Year Change
81.004%
3-Year Change
160.69%
5-Year Change
-75.57%
All-Time (Max) Change
-70.90%

Contact Information

650 752 1300
1330 O’Brien Drive, Fremont, CA, 94025

Company Facts

2,280 Employees
IPO DateJun 20, 2019
CountryUS
Actively Trading

Frequently Asked Questions